Showing results (641-650 of 1,071) with videos related to
Sort By:
Pageof 108
The International Journal of Biological Markers|March 18, 1999
High levels of cathepsin B predict poor outcome in patients with breast cancerT M Maguire, S G Shering, C M Duggan, et al.Diabetologia|November 8, 2005
Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetesD C Henstridge, B A Kingwell, M F Formosa, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|May 20, 1999
Chronic inhalation carcinogenicity study of commercial hexane solvent in F-344 rats and B6C3F1 miceW Daughtrey, P Newton, R Rhoden, et al.Pediatrics|June 4, 2008
Compliance in Rhode Island emergency departments with American Academy of Pediatrics recommendations for adolescent sexual assaultsRoland C Merchant, Erin T Kelly, Kenneth H Mayer, et al.Lancet (London, England)|August 27, 1994
Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancerH E Mulcahy, M J Duffy, D Gibbons, et al.Photoacoustics|May 1, 2018
Towards optimized naphthalocyanines as sonochromes for photoacoustic imaging <i>in vivo</i>Mitchell J Duffy, Oriol Planas, Andreas Faust, et al.Clinical and Experimental Pharmacology & Physiology|May 6, 2009
Oral nitrate therapy does not affect glucose metabolism in healthy menDarren C Henstridge, Stephen J Duffy, Melissa F Formosa, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolismH C Liang, H Li, R A McKinnon, et al.Circulation Research|September 1, 1994
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulationW Luo, I L Grupp, J Harrer, et al.Circulation|June 13, 2001
Iron chelation improves endothelial function in patients with coronary artery diseaseS J Duffy, E S Biegelsen, M Holbrook, et al.Pageof 108